T
Alaunos Therapeutics D
D
TCRT
2.39000
USD
0.29
(13.81%)
Market Closed
Volume
139
EPS
-0
Div Yield
-
P/E
-0
Market Cap
3,826,992
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Alaunos Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.